3YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| NSC 177223 | 4-Amino-5,6,7,8-tetrahydro-5-oxo-8-(β-D-ribofuranosyl)pyrido[2,3-d]pyrimidine-6-carboxamide | 36707-00-3 |
| BMS-191011 | 3-(5-CHLORO-2-HYDROXYBENZYL)-5-(4-(TRIFLUOROMETHYL)PHENYL)-1,3,4-OXADIAZOL-2(3H)-ONE | 202821-81-6 |
| LDN-192960 dihydrochloride | 3-[(2,7-二甲氧基吖啶-9-基)硫基]丙胺 | 184582-62-5 |
| SGA360 | SGA360 | 680611-86-3 |
| ISRIB | ISRIB | 548470-11-7 |
| TH588 | TH588 HYDROCHLORIDE | 1609960-31-7 |
| B355252 | 4-Chloro-N-(naphthalen-1-ylmethyl)-5-(3-(piperazin-1-yl)phenoxy)thiophene-2-sulfonamide | 1261576-81-1 |
| Apcin | Apcin | 300815-04-7 |
| CID-46943215 | G244-LM | 1563007-08-8 |
| ML162 | ML162 | 1035072-16-2 |
| A 286982 | A 286982 | 280749-17-9 |
| K02288 | K02288 | 1431985-92-0 |
| WS3 | 重复 | 1421227-52-2 |
| CH-5183284 | DEBIO-1347 | 1265229-25-1 |
| ML335 | ML335 | 1069498-96-9 |
| MLS-0315848 hydrochloride | MLS-0315848 hydrochloride | 1135318-57-8 |
| Mycro3 | 944547-46-0 | 944547-46-0 |
| ML191 | ML-191 | 931695-79-3 |
| BDP5290 | BDP5290 | 1817698-21-7 |
| JW 55 | JW-55 | 664993-53-7 |
| HA-155 | CS-963 | 1312201-00-5 |
| WIKI4 | 化合物WIKI4 | 838818-26-1 |
| NSC-703786 | 4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯胺 | 260443-89-8 |
| CRT0066101 | 10MG | 956121-30-5 |
| RO2959 hydrochloride | 化合物RO2959 HYDROCHLORIDE | 1219927-22-6 |
| AEM1 | AEM1 | 1030123-90-0 |
| ML179 | ML-179 | 1883548-87-5 |
| WAY-169916 | 1,3-Benzenediol, 4-[1-(2-propenyl)-7-(trifluoromethyl)-1H-indazol-3-yl]- | 669764-18-5 |
| ARN272 | ARN272 | 488793-85-7 |
| Kobe0065 | N-(3-CHLORO-4-METHYLPHENYL)-2-(2,6-DINITRO-4-(TRIFLUOROMETHYL)PHENYL)HYDRAZINECARBOTHIOAMIDE | 436133-68-5 |
| AA92593 | 4-Methoxy-3-methylphenyl piperidin-1-yl sulphone, 2-Methyl-4-[(piperidin-1-yl)sulphonyl]anisole | 457961-34-1 |
| ML277 | ML-277 | 1401242-74-7 |
| Mps1-IN-3 | 1609584-72-6 | 1609584-72-6 |
| PCNA-I 1 | PCNA-I1 | 444930-42-1 |
| CE3F4 | 143703-25-7 | 143703-25-7 |
| GSK5182 | CS-2620 | 877387-37-6 |
| GSK-843 | GSK-843 | 1601496-05-2 |
| CGS-15943 | CGS 15943 | 104615-18-1 |
| ML298 | ML298 | 1426916-02-0 |
| Imidazenil | 米达西尼 | 151271-08-8 |
| SR-8278 | SR8278 | 1254944-66-5 |
| KML-29 | KML-29 | 1380424-42-9 |
| NIBR 0213 | NIBR 0213 | 1233332-14-3 |
| Dafadine-A | CS-1223 | 1065506-69-5 |
| FPH2 | FPH2 | 957485-64-2 |
| SW155246 | 4-Chloro-N-(4-hydroxy-1-naphthalenyl)-3-nitro-benzenesulfonamide | 420092-79-1 |
| 4BP-TQS | 4BP-TQS | 360791-49-7 |
| TM5007 | 化合物TM5007 | 342595-05-5 |
| VK-II-36 | 化合物VK-II-43 | 955371-66-1 |
| B355252 | (E)-2-((1,4-二甲基哌嗪-2-亚基)氨基)-5-硝基-N-苯基苯甲酰胺 | 1613465-33-0 |
| PSB-SB-487 | 化合物PSB-SB-487 | 1399049-81-0 |
| BMS453 | BMS453 | 166977-43-1 |
| JTE-013 | JTE-013 | 383150-41-2 |
| Leukadherin-1 | 4-(5-((3-苄基-4-氧代-2-硫代噻唑烷-5-亚基)甲基)呋喃-2-基)苯甲酸 | 344897-95-6 |
| MCC950 sodium | MCC950 | 210826-40-7 |
| YMU1 | Ethyl 4-(2-(4,6-dimethyl-3-oxoisothiazolo[5,4-b]pyridin-2(3H)-yl)acetyl)piperazine-1-carboxylate | 902589-96-2 |
| CRT5 | CRT5 | 1034297-58-9 |
| ML-180 | ML-180 | 863588-32-3 |
| DD1 | 化合物DD1 | 187585-11-1 |
| SAR405 R enantiomer | SAR405 R enantiomer | 1946010-79-2 |
| ry785，Kv2-IN-A1 | 化合物RY785 | 689297-68-5 |
| Inauhzin | INAUHZIN | 309271-94-1 |
| PD089828 | PD089828 | 179343-17-0 |
| ASN03576800 | ASN03576800 | 957513-35-8 |
| PU-H54 | 化合物PU-H54 | 1454619-13-6 |
| GSK484 | CS-2265 | 652591-81-5 |
| RBC10 | RBC10 | 362503-73-9 |
| NMS-873 | 顺式-(Z)-氟哌噻吨二盐酸盐 | 51529-01-2 |
| GSK J1 | N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸 | 1373422-53-7 |
| GSK 2830371 | GSK 2830371 | 1404456-53-6 |
| PFK15 | PFK-015 | 4382-63-2 |
| ML 254 | ML 254 | 1428630-86-7 |
| SGC707 | N-6-异喹啉基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲 | 1687736-54-4 |
| FIT-039 | FIT-039 | 1113044-49-7 |
| R243 | VK II 86|||VKII86 | 955371-84-3 |
| ML-299 | ML-299 | 1426916-00-8 |
| CYM 2503 | (9H-芴-9 - 基)甲基((S)-1(((S)-6 - (叔丁氧基羰基)氨基-1 - ((4 - 甲基-2 - 氧代-1,2 - 二氢喹啉-7 - 基)氨基)-1 - 氧代己-2 - 基)氨基)-3 - 环己基-1 - 氧代丙-2 - 基)氨基甲酸叔丁酯 | 1308833-36-4 |
| 1,2,5-Oxadithiolane 2,2,5,5-tetr aoxide | 1,2,5-恶二硫烷2,2,5,5-四环氧乙烷 | 4378-87-4 |
| Carbamic acid | ((S)-5-((2R,3S)-3-(N-羟基甲酰胺基)-2-异丁基六氨基)-2-氧代-6-(噻唑-2-基氨基)己基)氨基甲酸苄酯 | 866924-39-2 |
| Ethyl 2-amino-4,4-diuoro-3-oxobutan oate hydrochloride | 2-氨基-4,4-二氟-3-氧代丁酸乙酯盐酸盐 | 1651167-45-1 |
| VPC23019 | VPC 23019 | 449173-19-7 |
| NMS 873 | NMS873 | 1418013-75-8 |
| Atglistatin | ATGLISTATIN | 1469924-27-3 |
| CYM50308 | CYM50308 | 1345858-76-5 |
| TH287 | TH287 | 1609960-30-6 |
| PF 9601N | PF 9601N | 133845-63-3 |
| ML303 | ML303 | 1638211-04-7 |
| HS-1793 | 化合物HS-1793 | 927885-00-5 |
| BPU-11 | BPU-11 | 909664-41-1 |
| 4'-Bromo-resveratrol | 5-[(E)-2-(4-溴苯基)乙烯基]间苯二酚 | 1224713-90-9 |
| ML-211 | 化合物ML-211 | 2205032-89-7 |
| YM26734 | YM 26734 | 144337-18-8 |
| Nisoxetine hydrochloride | 盐酸尼索西汀 | 57754-86-6 |
| Fluxapyroxad | 氟唑菌酰胺 | 907204-31-3 |
| TAE-1 | 2,2′,2′-[1,3,5-Triazine-2,4,6-triyltris(oxy-4,1-phenylenecarbonyloxy)]tris[N,N,N-trimethyl-ethanaminium tri-iodide | 1414469-59-2 |
| ML240 | ML240 | 1346527-98-7 |
| OS-3-106 | N-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)-4-(thiazol-4-yl)benzamide | 1580000-17-4 |
| GW779439X | 化合物GW779439X | 551919-98-3 |
| VUF11418 | N-[[(1R,5S)-6,6-二甲基双环[3.1.1]庚-2-烯-2-基]甲基]-2′-碘-N,N-二甲基[1,1′-联苯]-4-甲基碘化铵 | 1414376-85-4 |
| JCP174 | 7-Amino-4-chloro-3-propoxy-isochromen-1-one | 126062-19-9 |
联系方式
